Onconetix, Inc. Investments and Cash
Onconetix, Inc. (ONCO) had Investments and Cash of $900.00 thousand as of 2024-06-30, per its 10-Q filed 2024-08-29.
Discontinued › Balance Sheet › Assets
us-gaap:InvestmentsAndCash · last filed 2024-08-29
- 2024-06-30: Investments and Cash $900.00K.
- 2024-03-31: Investments and Cash $4.50M.
- 2023-09-30: Investments and Cash $7.70M.
- 2023-06-30: Investments and Cash $9.20M.
| Period end | Investments and Cash |
|---|---|
| 2024-06-30 | $900.00K 10-Q · filed 2024-08-29 |
| 2024-03-31 | $4.50M 10-Q · filed 2024-05-20 |
| 2023-09-30 | $7.70M 10-Q · filed 2023-11-17 |
| 2023-06-30 | $9.20M 10-Q · filed 2023-10-20 |
| 2023-03-31 | $20.30M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $25.80M 10-K · filed 2023-03-09 |
| 2022-09-30 | $29.10M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $22.20M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $18.60M 10-Q · filed 2022-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |